Breaking News

Sartorius Completes Acquisition of Novasep’s Chromatography Biz

For the Bioprocess Solutions Division, the company now forecasts sales revenue growth of about 17 to 21 percent for 2022.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sartorius Stedim Biotech completed the acquirsition of Novasep‘s chromatography process equipment division. Novasep’s division expects to generated sales of approximately €40 million in 2020 with double-digit profit margins. The company employs approximately 100 people, with the majority working at its Pompey site in northern France, as well as the U.S., China and India. Financial details were not disclosed. Novasep’s chromatography unit comprises resin-based batch and inten...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters